臨床研究支援部門

2015年業績（一部）　室谷健太

Murotani K, Hirakawa A, Aoyama Y, Yanagawa T
Follow-up Design for Comparing Two Binary Diagnostic Tests
Austin Biometrics and Biostatistics
2015; 2(2); 1016

Murotani K, Zhou B, Kaneda H, Nakatani E, Kojima S, Nagai Y, Fukushima M.
Survival of Centenarian in Japan.
J Biosoc Sci.
2015 Nov;47(6):707-17. doi: 10.1017/S0021932014000388.

Kanda M, Murotani K, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G,
Sugimoto H, Koike M, Fujiwara M, Kodera Y
Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and
prognostic factors among patients with stage II/III gastric cancer: A propensity
score matching analysis
Surgery.
2015 Dec;158(6):1573-80. doi: 10.1016/j.surg.2015.05.017.

Emura T and Murotani K
An algorithm for estimating survival under a copula-based dependent truncation model.
TEST.
2015; 24(4): 734-751 DOI: 10.1007/s11749-015-0432-8

Funahashi Y, Murotani K, Yoshino Y, Sassa N, Ishida S, Gotoh M
The renal tumor morphological characteristics that affect surgical planning for
laparoscopic or open partial nephrectomy.
Nagoya J Med Sci.
2015 Feb;77(1-2):229-35.

Emura T, Nakatochi M, Murotani K, Rondeau V
A joint frailty-copula model between tumour progression and death for meta-analysis.
Stat Methods Med Res.
2015 Sep 18. pii: 0962280215604510. [Epub ahead of print]

Fujii T, Nakao A, Murotani K, Okamura Y, Ishigure K, Hatsuno T, Sakai M, Yamada S,
Kanda M, Sugimoto H, Nomoto S, Takeda S, Morita S, Kodera Y
Influence of Food Intake on the Healing Process of Postoperative Pancreatic Fistula
After Pancreatoduodenectomy: A Multi-institutional Randomized Controlled Trial.
Ann Surg Oncol.
2015 Nov;22(12):3905-12. doi: 10.1245/s10434-015-4496-1.

Yabe D, Kuwata H, Kaneko M, Nishikino R, Murotani K, Kurose T, Seino Y.
Use of the Japanese health insurance claims database to assess the risk of acute
pancreatitis in patients with diabetes: Comparison of DPP-4 inhibitors with other
oral anti-diabetic drugs.
Diabetes, Obesity and Metabolism.
2015 17(4); 430-434.

Yabe D, Kuroe A, Watanabe K, Iwasaki M, Hamasaki A, Hamamoto Y, Harada N,
Yamane S, Lee S, Murotani K, Deacon C.F, Holst J.J, Hirano T, Inagaki N, Kurose
T, Seino Y.
Early phase glucagon and insulin secretory abnormalities, but not incretin secretion,
are similarly responsible for hyperglycemia after ingestion of nutrients.
J Diabetes Complications.
2015 Apr;29(3):413-21. doi: 10.1016/j.jdiacomp.2014.12.010.

Usui R, Yabe D, Kuwata H, Murotani K, Kurose T, Seino Y
Retrospective analysis of safety and efficacy of liraglutide monotherapy and
sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of
remaining β-cell function and achievement of HbA1c target one year after
initiation.
J Diabetes Complications.
2015 Nov-Dec;29(8):1203-10. doi: 10.1016/j.jdiacomp.2015.07.020.

Miyaoka T, Furuya M, Horiguchi J, Wake R, Hashioka S, Tohyama M, Mori N, Minabe Y,
Iyo M, Ueno S, Ezoe S, Murotani K, Hoshino S, Seno H.
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized,
double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale,
five-factor analysis)
Psychopharmacology (Berl).
2015 Jan;232(1):155-64. doi: 10.1007/s00213-014-3645-8.

室谷健太　業績（論文）　2015年発行されたものに限る(PDF:116 KB)